{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:48:25Z","timestamp":1773694105068,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clineuro.2026.109353","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:00:28Z","timestamp":1771358428000},"page":"109353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Communicating hydrocephalus in glioblastoma: Early predictors and implications for prognosis"],"prefix":"10.1016","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9990-1076","authenticated-orcid":false,"given":"Francesca","family":"Roncelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Snider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierfrancesco","family":"De Domenico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina Raffaella","family":"Barzaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Acerno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Mortini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-1764","authenticated-orcid":false,"given":"Filippo","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12 2","key":"10.1016\/j.clineuro.2026.109353_bib1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol."},{"issue":"10","key":"10.1016\/j.clineuro.2026.109353_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med"},{"issue":"11","key":"10.1016\/j.clineuro.2026.109353_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.clineuro.2026.109353_bib4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3389\/fonc.2020.00840","article-title":"Real-world evidence in glioblastoma: stupp's regimen after a decade","volume":"10","author":"Lakomy","year":"2020","journal-title":"Front Oncol."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109353_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043208","article-title":"Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway","volume":"11","author":"Bjorland","year":"2021","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.clineuro.2026.109353_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109353_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1470-2045(18)30675-2","article-title":"Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial","volume":"20","author":"Lombardi","year":"2019","journal-title":"Lancet Oncol."},{"issue":"18","key":"10.1016\/j.clineuro.2026.109353_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184731","article-title":"Regorafenib in recurrent glioblastoma patients: a large and monocentric real-life study","volume":"13","author":"Lombardi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clineuro.2026.109353_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fneur.2019.00286","article-title":"A meta-analysis of survival outcomes following reoperation in recurrent glioblastoma: time to consider the timing of reoperation","volume":"10","author":"Zhao","year":"2019","journal-title":"Front Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2026.109353_bib10","article-title":"Stereotactic radiosurgery for recurrent glioblastoma multiforme: a retrospective multi-institutional experience","volume":"13","author":"Lovo","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109353_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12987-018-0101-x","article-title":"Challenges in cerebrospinal fluid shunting in patients with glioblastoma","volume":"15","author":"Hong","year":"2018","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109353_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00701-024-06414-2","article-title":"Communicating hydrocephalus in glioblastoma presenting as chronic hydrocephalus: systematic review and meta-analysis","volume":"167","author":"Perez-Alfayate","year":"2025","journal-title":"Acta Neurochir. (Wien. )"},{"issue":"6","key":"10.1016\/j.clineuro.2026.109353_bib13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3171\/2011.8.JNS11738","article-title":"Communicating hydrocephalus following surgery and adjuvant radiochemotherapy for glioblastoma","volume":"115","author":"Montano","year":"2011","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2026.109353_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clineuro.2014.02.012","article-title":"Hydrocephalus after resection and adjuvant radiochemotherapy in patients with glioblastoma","volume":"120","author":"Fischer","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109353_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1227\/NEU.0000000000001263","article-title":"Ventriculoperitoneal shunting for glioblastoma: risk factors, indications, and efficacy","volume":"80","author":"Castro","year":"2017","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.clineuro.2026.109353_bib16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/neuonc\/noac193","article-title":"Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the RANO resect group","volume":"25","author":"Karschnia","year":"2023","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109353_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s007010200030","article-title":"Delayed hydrocephalus after resection of supratentorial malignant gliomas","volume":"144","author":"Marquardt","year":"2002","journal-title":"Acta Neurochir. (Wien. )"},{"issue":"4","key":"10.1016\/j.clineuro.2026.109353_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5114\/fn.2017.72389","article-title":"Levels of selected pro- and anti-inflammatory cytokines in cerebrospinal fluid in patients with hydrocephalus","volume":"55","author":"Czubowicz","year":"2017","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.clineuro.2026.109353_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8834822","article-title":"Inflammatory markers in cerebrospinal fluid from patients with hydrocephalus: a systematic literature review","volume":"2021","author":"Lolansen","year":"2021","journal-title":"Dis. Markers"},{"issue":"6","key":"10.1016\/j.clineuro.2026.109353_bib20","first-page":"1984","article-title":"A sustained systemic inflammatory response syndrome is associated with shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage","volume":"130","author":"Wessell","year":"2019","journal-title":"J. Neurosurg."},{"issue":"10","key":"10.1016\/j.clineuro.2026.109353_bib21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.clineuro.2026.109353_bib22","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3390\/curroncol28020136","article-title":"On the prognosis of multifocal glioblastoma: an evaluation incorporating volumetric MRI","volume":"28","author":"Kasper","year":"2021","journal-title":"Curr. Oncol."},{"issue":"13","key":"10.1016\/j.clineuro.2026.109353_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133161","article-title":"Survival Outcomes and Prognostic Factors in Glioblastoma","volume":"14","author":"Brown","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clineuro.2026.109353_bib24","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1016\/j.wneu.2022.12.052","article-title":"Effect of extent of resection on survival of patients with glioblastoma, IDH-Wild-Type, WHO Grade 4 (WHO 2021): Systematic Review and Meta-Analysis","volume":"171","author":"Jusue-Torres","year":"2023","journal-title":"World Neurosurg."},{"issue":"11","key":"10.1016\/j.clineuro.2026.109353_bib25","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","article-title":"Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis","volume":"2","author":"Brown","year":"2016","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109353_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00701-007-1454-0","article-title":"The value of ventriculo-peritoneal shunting in patients with glioblastoma multiforme and ventriculomegaly","volume":"150","author":"Roth","year":"2008","journal-title":"Acta Neurochir. (Wien. )"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109353_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/acn3.17","article-title":"The role of ventriculoperitoneal shunting in patients with supratentorial glioma","volume":"1","author":"de la Fuente","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109353_bib28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3171\/2020.7.JNS201362","article-title":"Effects of ventricular entry on patient outcome during glioblastoma resection","volume":"135","author":"Young","year":"2021","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2026.109353_bib29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.wneu.2017.07.034","article-title":"The prognostic impact of ventricular opening in glioblastoma surgery: a retrospective single center analysis","volume":"106","author":"Behling","year":"2017","journal-title":"World Neurosurg."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:58:12Z","timestamp":1773691092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846726000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["S0303846726000454"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109353","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Communicating hydrocephalus in glioblastoma: Early predictors and implications for prognosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109353"}}